文献速递产科母胎医学

母体阿奇霉素治疗羊膜腔内微小脲原体感染改善非人灵长类胎儿血流动力学

Maternal azithromycin therapy for Ureaplasma parvum intraamniotic infection improves fetal hemodynamics in a nonhuman primate model.
PubMed 文献 · Am J Obstet Gynecol · 2020-04-25

本研究在慢性导管置入的孕恒河猴中,比较对照组、羊膜腔接种微小脲原体组及感染后阿奇霉素治疗组的胎儿血流动力学与心功能。结果发现感染组脐动脉和肺动脉血管阻抗显著升高、左心室输出量显著降低,阿奇霉素治疗使上述指标恢复至对照水平。

要点

  • 羊膜腔微小脲原体感染可致胎儿脐动脉和肺动脉阻抗升高及左心室输出量降低。
  • 母体静脉阿奇霉素治疗使感染所致的胎儿血流动力学异常恢复至对照水平。
  • 多普勒超声指标有望用于识别宫内感染相关胎儿心血管受累并评估治疗。

核心结论

  • 胎儿血流动力学改变与羊膜腔微小脲原体感染相关,母体抗生素治疗后可改善。

研究设计与样本

  • 慢性导管置入的孕恒河猴随机分为对照(n=6)、羊膜腔接种微小脲原体(10^7 CFU/mL,n=15)及感染加阿奇霉素治疗(12.5 mg/kg 每日两次静脉,n=8)三组。
  • 在约135天胎龄(足月165天)时用脉冲和彩色多普勒超声测量胎儿血流动力学与心功能指标。

主要发现

  • 羊膜腔接种微小脲原体组脐动脉和胎儿肺动脉血管阻抗显著升高(P<.05)。
  • 阿奇霉素治疗使上述血管阻抗值恢复至对照水平。
  • 脐动脉搏动指数异常(>1.1)的动物羊水前列腺素F2α水平显著高于血流正常者(P<.05;Spearman ρ=0.6,P<.05)。
  • 感染组左心室输出量显著降低(P<.001),更多动物出现右/左心室输出量比值异常(定义为>1.6,P<.05)。
  • 右/左心室输出量比值异常者羊水白介素-6浓度显著高于正常者(P<.05)。

临床怎么用

  • 多普勒超声测量可作为识别宫内感染或炎症相关胎儿心血管及血流动力学受累的候选诊断方法,并用于评估治疗干预或早产临床管理。

局限性

  • 研究为动物模型,样本量有限,结论外推至人类临床需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ureaplasma parvum infection is a prevalent cause of intrauterine infection associated with preterm birth, preterm premature rupture of membranes, fetal inflammatory response syndrome, and adverse postnatal sequelae. Elucidation of diagnostic and treatment strategies for infection-associated preterm labor may improve perinatal and long-term outcomes for these cases. OBJECTIVE: This study assessed the effect of intraamniotic Ureaplasma infection on fetal hemodynamic and cardiac function and the effect of maternal antibiotic treatment on these outcomes. STUDY DESIGN: Chronically catheterized pregnant rhesus monkeys were assigned to control (n=6), intraamniotic inoculation with Ureaplasma parvum (107 colony-forming units/mL, n=15), and intraamniotic infection plus azithromycin treatment (12.5 mg/kg twice a day intravenously, n=8) groups. At approximately 135 days' gestation (term=165 days), pulsed and color Doppler ultrasonography was used to obtain measurements of fetal hemodynamics (pulsatility index of umbilical artery, ductus venosus, descending aorta, ductus arteriosus, aortic isthmus, right pulmonary artery, middle cerebral artery and cerebroplacental ratio, and left and right ventricular cardiac outputs) and cardiac function (ratio of peak early vs late transmitral flow velocity [marker of ventricular function], Tei index [myocardial performance index]). These indices were stratified by amniotic fluid proinflammatory mediator levels and cardiac histology. RESULTS: Umbilical and fetal pulmonary artery vascular impedances were significantly increased in animals from the intraamniotic inoculation with Ureaplasma parvum group (P<.05). Azithromycin treatment restored values to control levels. Amniotic fluid prostaglandin F2 alpha levels were significantly higher in animals with abnormal umbilical artery pulsatility index (>1.1) than in those with normal blood flow (P<.05; Spearman ρ=0.6, P<.05). In the intraamniotic inoculation with Ureaplasma parvum group, left ventricular cardiac output was significantly decreased (P<.001), and more animals had abnormal right-to-left ventricular cardiac output ratios (defined as >1.6, P<.05). Amniotic fluid interleukin-6 concentrations were elevated in cases of abnormal right-to-left ventricular cardiac output ratios compared with those in normal cases (P<.05). CONCLUSION: Fetal hemodynamic alterations were associated with intraamniotic Ureaplasma infection and ameliorated after maternal antibiotic treatment. Doppler ultrasonographic measurements merit continuing investigation as a diagnostic method to identify fetal cardiovascular and hemodynamic compromise associated with intrauterine infection or inflammation and in the evaluation of therapeutic interventions or clinical management of preterm labor.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kelleher MA, Lee JY, Roberts VHJ, et al. Maternal azithromycin therapy for Ureaplasma parvum intraamniotic infection improves fetal hemodynamics in a nonhuman primate model. Am J Obstet Gynecol. 2020. PMID: 32343954. doi:10.1016/j.ajog.2020.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。